Belgium
BOTALYS, founded in 2011 and headquartered in Belgium, is transforming the landscape of agritech and biotechnology through its pioneering approach to sourcing rare medicinal plants. The company’s mission, encapsulated in its slogan, "We make the impossible sourcing of rare medicinal plants flawless," highlights its commitment to sustainable and premium-quality botanical production.
BOTALYS utilizes a proprietary Biomimetic Farming Technology that leverages indoor vertical farming to simulate ideal wild growth conditions. This technique allows BOTALYS to produce medicinal plants with lab-like purity while maintaining wild-quality standards. Their flagship product, a full-spectrum Korean Red Ginseng root powder, is esteemed for its exceptional equivalence to a 20-year-old wild specimen, underscoring BOTALYS’s capability in molecular profile enhancement.
In October 2022, BOTALYS secured a €6.60M Series B investment, with participation from leading investors such as The Yield Lab, WAPINVEST, Air Liquide, SEPPIC, Vives Partners, and Wallonie Entreprendre, indicating strong market confidence in their innovation and growth potential.
